Handelsbanken Fonder AB - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2022$280,000
-24.3%
9,0090.0%0.00%0.0%
Q1 2022$370,000
-5.6%
9,0090.0%0.00%0.0%
Q4 2021$392,000
-13.1%
9,0090.0%0.00%0.0%
Q3 2021$451,000
-20.5%
9,0090.0%0.00%
-33.3%
Q2 2021$567,000
-20.8%
9,009
+16.9%
0.00%
-25.0%
Q1 2021$716,000
+3.6%
7,7090.0%0.00%0.0%
Q4 2020$691,000
-13.3%
7,7090.0%0.00%
-33.3%
Q3 2020$797,000
-34.7%
7,709
-50.0%
0.01%
+20.0%
Q2 2020$1,220,00015,4180.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders